Critical Care

official impact factor 4.60

Email this article to a friend

Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis – practical aspects at the bedside and patient identification

Pierre-François Laterre* and Xavier Wittebole

Critical Care 2003, 7:445-450 doi:10.1186/cc2342

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.